GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent BioSolutions Inc (STU:ER4) » Definitions » Inventories, Raw Materials & Components

Emergent BioSolutions (STU:ER4) Inventories, Raw Materials & Components : €120 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Emergent BioSolutions Inventories, Raw Materials & Components?

Emergent BioSolutions's inventories, raw materials & components for the quarter that ended in Mar. 2024 was €120 Mil.

Emergent BioSolutions's quarterly raw materials declined from Sep. 2023 (€133 Mil) to Dec. 2023 (€118 Mil) but then increased from Dec. 2023 (€118 Mil) to Mar. 2024 (€120 Mil).

Emergent BioSolutions's annual raw materials declined from Dec. 2021 (€188 Mil) to Dec. 2022 (€134 Mil) and declined from Dec. 2022 (€134 Mil) to Dec. 2023 (€118 Mil).


Emergent BioSolutions Inventories, Raw Materials & Components Historical Data

The historical data trend for Emergent BioSolutions's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent BioSolutions Inventories, Raw Materials & Components Chart

Emergent BioSolutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.45 132.01 188.33 134.33 118.02

Emergent BioSolutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139.07 129.50 133.34 118.02 120.06

Emergent BioSolutions Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Emergent BioSolutions (STU:ER4) Business Description

Industry
Traded in Other Exchanges
Address
400 Professional Drive, Suite 400, Gaithersburg, MD, USA, 20879
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.

Emergent BioSolutions (STU:ER4) Headlines

No Headlines